Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Insmed shares have been knocked around by negative headlines on the development side, but the company already has a commercially approved DPP1 inhibitor, BRINSUPRI, with consensus peak sales potential near $5 billion. With a market cap of roughly $33.5 billion and supportive technicals, this trade idea buys the pullback into what we view as an othe…
A recent WarrenAI analysis spotlights three established companies that pair growth momentum with solid financial metrics. Cigna, First Solar and Newmont each show notable revenue expansion and analyst upside potential, while WarrenAI rates their financial health positively. These selections span healthcare, clean energy and precious metals, reflect…
Cantor Fitzgerald raised its price target on Regeneron Pharmaceuticals to $800 from $740 and kept an Overweight rating after updating near-term commercial portfolio estimates and applying modest values to several development programs. The firm highlighted obesity efforts, Dupixent lifecycle management and Factor XI research as drivers of higher val…
Scotiabank raised its 12-month price target for Verizon Communications to $50.25 from $48.00 while keeping a Sector Perform rating, citing the carrier's new churn-reduction plan and the inclusion of the Frontier acquisition in updated estimates. The bank says Verizon shares still look inexpensive, but it wants to see initial evidence that churn is …
Cantor Fitzgerald has maintained an Overweight rating on Definium Therapeutics Inc (NASDAQ:DFTX), while revising key inputs in its valuation model. The firm lowered its discount rate and adjusted penetration assumptions for two psychiatric indications, increasing its NPV estimate materially even as it trimmed EPS forecasts for 2025 and 2026. Other …
Greenland’s Prime Minister Jens-Frederik Nielsen told parliament that, despite U.S. President Donald Trump having ruled out the use of military force, Washington continues to pursue control and pathways to ownership of the Arctic island. Trump intensified calls earlier in the year for U.S. control citing national security concerns tied to Russia an…
Stephens raised its price objective on Ameris Bancorp to $87 from $79 while keeping an Equal Weight rating, citing stronger-than-expected core pre-provision net revenue (PPNR) and a firmer net interest margin (NIM). The new target implies roughly 8% upside from the stock's prevailing level and comes amid continued loan growth, elevated production, …
William Blair moved Palantir Technologies Inc. (PLTR) from Market Perform to Outperform on Monday, pointing to sustained momentum in both government and commercial channels. The upgrade, issued before Palantir’s upcoming earnings, notes strong tracker data, large partnership expansions, and enterprise adoption, even as the stock has experienced a s…
Stephens reduced its 12-month price target for Canadian National Railway (CNI) to $100 from $105 while retaining an Equal Weight rating. The move follows Q4 2025 results that beat estimates on adjusted EPS and operating ratio, but the firm cited flat revenue ton mile guidance, macroeconomic and trade-policy uncertainty, and rising expenses that lim…
Uber has confirmed it is engaged in discussions with France's social security agency URSSAF after media reports said the agency concluded tens of thousands of drivers should have been classified as employees. URSSAF is reported to be seeking substantial back payments and penalties. The matter sits alongside ongoing court scrutiny of app-based ride-…
Shares of several U.S. rare earths and critical minerals companies rose sharply after reports that the administration plans a $12 billion strategic minerals stockpile, an initiative aimed at reducing dependence on Chinese supplies. The proposal - informally referred to as Project Vault - would pair private capital with a large loan from the U.S. Ex…
Bernstein SocGen Group lowered its price target on Qualcomm to $200 from $215 while maintaining an Outperform rating. The firm cited weak sentiment toward smartphones, Apple rolloff concerns and recent memory-market dynamics as reasons for the cut, even as it highlighted Qualcomm’s strong product lineup, robust cash generation and emerging AI adjac…
Bernstein SocGen Group lowered its price target on Elevance (NYSE: ELV) to $409 from $431 while keeping an Outperform rating. The firm pointed to Elevance’s $25.50 per share guidance for 2025 and mixed fourth-quarter 2025 results - an adjusted EPS beat alongside revenue that missed expectations - as the drivers of the adjustment. Bernstein flagged …
Bernstein SocGen Group increased its price target on Air Products & Chemicals Inc. (NYSE: APD) to $315.00 from $300.00 while keeping an Outperform rating, pointing to successful execution of a 'back to basics strategy' demonstrated in the company’s first-quarter fiscal 2026 performance. The research house highlighted productivity progress, a favora…
Bernstein SocGen Group raised its price target for Regeneron Pharmaceuticals to $925 from $916 while retaining an Outperform rating, citing a solid quarter, robust cash flow and profitability metrics, and upcoming Phase 3 melanoma data for the company’s LAG3 inhibitor. Other firms have also updated targets following Regeneron’s fourth-quarter 2025 …
Saudi Arabia's stock market closed higher on Monday, with the Tadawul All Share index up 1.38% as gains in several sectors outpaced declines. Leading individual advances included Saudi Pharmaceutical Appliances, Rasan Information Technology - which reached an all-time high - and Knowledge Economic City, while select mining and industrial names lagg…
JPMorgan raised its price target on Chevron to $181 from $176 while retaining an Overweight rating, highlighting cost-savings targets tied to structural reductions and post-merger investment positioning. The bank pointed to debottlenecking at major projects and a geographically diversified upstream portfolio as potential catalysts, while recent ear…
H.C. Wainwright has reaffirmed a Buy rating and a $40.00 12-month price target on Summit Therapeutics plc (NASDAQ:SMMT) after the U.S. Food and Drug Administration accepted the company’s Biologics License Application for ivonescimab. The price target implies a roughly 176% upside from Summit’s recent trading level near its 52-week low. The FDA set …
Investment bank Mizuho raised its price target on AXIS Capital (NYSE: AXS) to $141.00 from $133.00 and kept an Outperform rating, citing robust end-of-2025 operating trends. The upgrade reflects accelerating premium growth, stable underlying loss ratios, nearly $900 million of share buybacks by year-end and improved prior-year loss development, alo…
JPMorgan raised its price target on ExxonMobil to $140 from $133 and kept an Overweight rating after the company posted stronger-than-expected fourth-quarter 2025 results. Earnings per share and operating cash flow exceeded both the bank's and consensus forecasts, and ExxonMobil completed a suite of major 2025 projects expected to add roughly $3 bi…
JPMorgan reiterated an Overweight rating and a $510.00 price target on Carvana (NYSE: CVNA), highlighting the firm’s early and sustained focus on online-only used-vehicle retailing as a structural advantage. The stock, trading at $401.11, implies roughly 27% upside to JPMorgan’s target despite a recent drop of over 15% in the past week. The bank no…
H.C. Wainwright has reaffirmed a Buy rating and an $18.00 price target on Coya Therapeutics (NASDAQ:COYA) after the company completed a private placement that generated roughly $11.1 million in gross proceeds. The analyst house views the financing as extending Coya’s operational runway into late 2027 and highlights investor support from Dr. Reddy’s…
H.C. Wainwright initiated coverage of Hut 8 Mining Corp. (HUT) with a Buy rating and set a $80.00 price target. The firm highlighted the company's pivot toward digital infrastructure through long-term data center agreements, notably deals with Fluidstack and Anthropic, and emphasized Google’s financial support for the River Bend project as a credit…
Morgan Stanley increased its price target on Colgate-Palmolive Co. (CL) to $100 from $87 while keeping an Overweight rating, highlighting mid-single-digit organic growth in emerging markets that helped drive 3.1% fourth-quarter organic sales excluding pet-product discontinuations. The stock trades near $90.29, with momentum indicators signaling ove…
Needham has reiterated a Buy rating on JFrog with a $70 price target, highlighting the company's position in software supply-chain security. Trading at $54.80, the shares imply about 28% upside per InvestingPro data. Multiple sell-side firms maintain constructive views as the company prepares to report fourth-quarter results amid recent security di…
